Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sylvain eLehmann"'
Autor:
Babette eReijs, Charlotte Elisabeth Teunissen, Nikolai eGoncharenko, Fay eBetsou, Kaj eBlennow, Inês eBaldeiras, Frederic eBrosseron, Enrica eCavedo, Tormod eFladby, Lutz eFroelich, Tomasz eGabryelewicz, Hakan eGurvit, Elisabeth eKapaki, Peter eKoson, Luka eKulic, Sylvain eLehmann, Piotr eLewczuk, Alberto eLleó, Walter eMaetzler, Alexandre ede Mendonça, Anne-Marie eMiller, José Luis eMolinuevo, Brit eMollenhauer, Lucilla eParnetti, Uros eRot, Anja eSchneider, Anja Hviid Simonsen, Fabrizio eTagliavini, Magda eTsolaki, Marcel M Verbeek, Marzena eZboch, Frans R Verhey, Bengt eWinblad, Philip eScheltens, Henrik eZetterberg, Pieter Jelle eVisser
Publikováno v:
Frontiers in Neurology, Vol 6 (2015)
AbstractBiobanks are important resources for biomarker discovery and assay development. Biomarkers for Alzheimer's and Parkinson's Disease (BIOMARKAPD) is a European multicenter study, funded by the EU Joint Programme - Neurodegenerative Disease Rese
Externí odkaz:
https://doaj.org/article/c94931ab125f456c8ce268fff21d6830
Autor:
Pauline eBros, Jérome eVialaret, Nicolas eBarthelemy, Vincent eDelatour, Audrey eGabelle, Sylvain eLehmann, Christophe eHirtz
Publikováno v:
Frontiers in Neuroscience, Vol 9 (2015)
Tau protein concentration in cerebrospinal fluid (CSF) is currently used as a sensitive and specific biomarker for Alzheimer's disease. Its detection currently relies on ELISA but the perspective of using mass spectrometry (MS) to detect its differen
Externí odkaz:
https://doaj.org/article/a319e106cfa145a0bb99d43c2f99d7db
Autor:
Constance eDELABY, Audrey eGABELLE, David eBLUM, Susanna eSCHRAEN MASCHKE, Amandine eMOULINIER, Justine eBOULANGIEN, Dany eSEVERAC, Luc eBUEE, Thierry eREME, Sylvain eLEHMANN
Publikováno v:
Frontiers in Neurology, Vol 6 (2015)
Brain inflammation is one of the hallmarks of Alzheimer disease (AD) and a current trend is that inflammatory mediators, particularly cytokines and chemokines, may represent valuable biomarkers for early screening and diagnosis of the disease. Variou
Externí odkaz:
https://doaj.org/article/dfe3867be84242d68cbace0b18becdbb
Publikováno v:
Frontiers in Aging Neuroscience, Vol 6 (2014)
Objective: To examine relationships between cerebrospinal fluid (CSF) Alzheimer’ disease (AD) biomarkers and hypocretin-1 levels in patients with cognitive abnormalities and hypocretin-deficient narcolepsy-cataplexy (NC), estimate diagnostic accura
Externí odkaz:
https://doaj.org/article/58c4b8a7bd2846a9acf9fe1b217fef68